We use metabolomics as a key "bridge" between genetics and phenotypes to empower precision medicine through a new precision health management model utilizing big data technologies, artificial intelligence, 5G, cloud, and other technical services.

Furthermore, as the demand for instant, rapid testing grows, the we are actively promoting the development of ultrasensitive, fast, and portable detection devices. Many tests that could previously only be performed in clinical settings can now be handled in a variety of complex scenarios, allowing for simpler, faster, and more efficient disease detection.